Oh Sang-Hoon, Sung Won-Sub, Oh So-Hee, Jo Chris Hyunchul
Department of Orthopedic Surgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Dongjak-gu, Seoul, Korea.
Department of Translational Medicine, Seoul National University College of Medicine, Jongno-gu, Seoul, Korea.
JSES Int. 2021 Sep 16;5(6):1091-1104. doi: 10.1016/j.jseint.2021.07.017. eCollection 2021 Nov.
Few studies have reported the effects of simultaneous injections of corticosteroid (CS) and hyaluronic acid (HA) on adhesive capsulitis (AC) of the shoulder. This study investigated the synergistic effects of simultaneous intra-articular injections of CS and compared them to those of CS or HA alone.
Sixty patients with AC were enrolled in this randomized, placebo-controlled trial. The participants were divided into 4 groups: saline, CS, HA, and CS with HA groups. The primary outcome measure was changes in the Shoulder Pain and Disability Index (SPADI) scores at one month. The secondary outcome measures included changes in pain, range of motion, muscle strength, and additional shoulder functional scores at 1 day, 1 week, and 1, 3, and 6 months after injection.
After 1 month, changes of the SPADI scores were significantly higher in the CS with HA group (-58.4%) than those in the saline (-7.7%) and HA (-14.4%) groups. The score changed more in the CS with HA group than that in the CS group (-43.7%), but there was no significant difference. In the changes in pain, the CS with HA group showed significantly better and faster effects than the saline and HA groups. In the changes of range of motion, functional scores, the CS with HA group showed better results than the saline and HA groups.
In the treatment of AC, the simultaneous injection of CS and HA was more effective in improving SPADI scores at one month after injection than a single injection of CS or HA.
很少有研究报道同时注射皮质类固醇(CS)和透明质酸(HA)对肩周炎(AC)的影响。本研究调查了关节内同时注射CS的协同作用,并将其与单独注射CS或HA的效果进行比较。
60例AC患者纳入这项随机、安慰剂对照试验。参与者分为4组:生理盐水组、CS组、HA组和CS联合HA组。主要结局指标是1个月时肩痛和功能障碍指数(SPADI)评分的变化。次要结局指标包括注射后1天、1周以及1、3和6个月时疼痛、活动范围、肌肉力量的变化以及额外的肩部功能评分。
1个月后,CS联合HA组的SPADI评分变化(-58.4%)显著高于生理盐水组(-7.7%)和HA组(-14.4%)。CS联合HA组的评分变化大于CS组(-43.7%),但差异无统计学意义。在疼痛变化方面,CS联合HA组的效果明显优于生理盐水组和HA组,且起效更快。在活动范围和功能评分变化方面,CS联合HA组的结果优于生理盐水组和HA组。
在AC的治疗中,同时注射CS和HA在注射后1个月改善SPADI评分方面比单独注射CS或HA更有效。